Company Overview Leadership Corporate Strategy Product Pipeline Strategic Partnerships Financing Ion Channels as Drug Targets Platform Technologies Scientific Publications Intellectual Property Clinical and Preclinical Programs Research Programs Press Releases Press Contacts Events Calendar Message from CEO Our People Opportunities Benefits <  HOME  <  IR OVERVIEW  <  CORPORATE GOVERNANCE - MANAGEMENT TEAM CORPORATE GOVERNANCE - MANAGEMENT TEAM Highlights | Board of Directors | Management Team | Committee Composition P. Kay Wagoner, Ph.D. President, Chief Executive Officer and Director Richard D. Katz, M.D. Executive Vice President, Finance and Corporate Development, Chief Financial Officer Seth V.  Hetherington, M.D. Senior Vice President, Clinical and Regulatory Affairs Douglas S. Krafte, Ph.D. Vice President - Biology and Scientific Affairs Gregory C. Rigdon, Ph.D. Vice President, New Product Development Mark J. Suto, Ph.D. Vice President of Chemical and Pharmaceutical Sciences Gregory  S. Shotzberger, Ph.D. Vice President, Business Development Robert J. Jakobs, C.M.A. Senior Director, Finance, and Assistant Secretary IR Overview Press Releases Stock Information Analyst Coverage Earnings Estimates SEC Filings Events Calendar Webcasts & Presentations Corporate Governance Information Request E-mail Alerts

Contact Us     Directions      Site Map Copyright © 2007 Icagen, Inc.   All rights reserved